Valeant Says Investors' Suit Is Based On Hindsight
A proposed class of investors claiming Valeant Pharmaceuticals International Inc. fraudulently hid questionable relationships with specialty pharmacies and is liable for a massive stock drop relied on hindsight following a "perfect...To view the full article, register now.
Already a subscriber? Click here to view full article